Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sorafenib for liver cancer: the horizon broadens.

× No keyword cloud information.

4 in total

1. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.

Authors: Alok R Singh; Shweta Joshi; Adam M Burgoyne; Jason K Sicklick; Sadakatsu Ikeda; Yuko Kono; Joseph R Garlich; Guillermo A Morales; Donald L Durden
Journal: Mol Cancer Ther Date: 2016-08-05 Impact factor: 6.261

2. Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma.

Authors: Ming Hong; Honghui Cheng; Lei Song; Wencai Wang; Qi Wang; Donggang Xu; Weiwei Xing
Journal: Molecules Date: 2018-02-11 Impact factor: 4.411

3. Combination treatment with sorafenib and wh-4 additively suppresses the proliferation of liver cancer cells.

Authors: Su-Hong Chen; Dan-Dan Xu; Peng-Jun Zhou; Yao Wang; Qiu-Ying Liu; Zhe Ren; Zhong Liu; Xia Wang; Hui-Qing Huang; Xue Xue; Ying Wang; Yi-Fei Wang
Journal: Exp Ther Med Date: 2022-01-20 Impact factor: 2.447

4. Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma.

Authors: Qiang-Bo Zhang; Hui-Chuan Sun; Ke-Zhi Zhang; Qing-An Jia; Yang Bu; Miao Wang; Zong-Tao Chai; Quan-Bao Zhang; Wen-Quan Wang; Ling-Qun Kong; Xiao-dong Zhu; Lu Lu; Wei-Zhong Wu; Lu Wang; Zhao-You Tang
Journal: PLoS One Date: 2013-02-08 Impact factor: 3.240

4 in total